Biguanides
RyMed Receives FDA Clearance for InVision-Plus CS Needleless IV Connector
Published in Medical Letter on the CDC and FDA, August 29th, 2010
The InVision-Plus CS is the only needleless IV connector to offer the combined antibacterial protection of chlorhexidine and silver - providing a septum that is impregnated with chlorhexidine and silver ions, and a silver-impregnated fluid pathway. This antibacterial protection encompasses both the fluid spike and the catheter hub.
The InVision-Plus CS connector combines chlorhexidine and silver impregnation with the proven design features of the InVision-Plus® with Neutral...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Cultured Cells
FDA Seeks Injunction Against Colorado Manufacturer of Cultured Cell Product - Environment
Green Bottles Offer an Environmentally Friendly Alternative to Traditional Plastic Water Bottles - Pneumoconiosis
Research from A.S. Laney et al has provided new information about pneumoconiosis - Heart Disease
Studies from Center for Drug Evaluation and Research describe new findings in heart disease - Agrochemicals
Study data from Food & Drug Administration update understanding of agrochemicals - Infection Control
New Always on Air-sanitizer Fills Critical Gap in Infection Control - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
